Novacyt Chiffre d’affaires 2018 Paris, France et Camberley, UK – 22 Janvier 2019 – Novacyt (EURONEXT GROWTH : ALNOV; AIM: NCYT), spécialiste international du diagnostic clinique, annonce son chiffre d’affaires non audité pour l’exercice clos le 31 décembre 2018.
Visit PageYear: 2019
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers http://novacyt.com/wp-content/uploads/2019/01/NOVACYT_CP_Droits-de-vote_2019-Jan.pdf
Visit PageLiquidity Agreement Monthly Update and Total Voting Rights
Paris, France and Camberley, UK – 2 January 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is further summarised
Visit Page